US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 1.6119
  • -0.0231-1.41%
Trading May 10 11:01 ET
12.77MMarket Cap-805P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.59%-16.43M
-14.10%-21.5M
-76.21%-8.57M
31.93%-5.05M
-11.19%-18.85M
-5M
-121.36%-1.56M
-13.86%-4.87M
4.15%-7.42M
-31.21%-16.95M
Net income from continuing operations
43.61%-10.01M
-1.86%-17.75M
-30.68%-5.68M
11.34%-5.18M
-2.01%-17.42M
---5.79M
-258.89%-1.45M
41.58%-4.35M
-55.88%-5.84M
-1.40%-17.08M
Operating gains losses
-28.91%-6.85M
-2,292.55%-5.32M
23.60%-54.14K
-131.02%-82.36K
123.15%242.5K
--49.21K
99.90%-1.33K
-104.67%-70.87K
123.68%265.48K
-356.84%-1.05M
Depreciation and amortization
0.00%4K
-3.05%4K
-10.11%942
-2.71%1.01K
-53.68%4.13K
--1.01K
4.87%1.03K
-65.57%1.05K
-73.33%1.03K
-53.62%8.91K
Other non cash items
--142K
----
----
----
----
----
----
----
----
--900K
Change In working capital
-205.35%-866K
141.44%822K
-457.39%-2.96M
105.66%109.3K
-3,465.71%-1.98M
--656.9K
57.54%-177.73K
-177.79%-531.66K
35.14%-1.93M
-101.80%-55.63K
-Change in prepaid assets
-95.88%70K
197.52%1.7M
-450.96%-465.62K
28.99%-442.85K
-1,007.17%-1.74M
---960.12K
-188.11%-291.19K
-11.02%132.67K
44.09%-623.63K
-72.96%192.05K
-Change in payables and accrued expense
-6.73%-936K
-263.43%-877K
-272.24%-2.47M
142.23%552.16K
2.57%-241.31K
--1.62M
115.15%113.45K
-224.32%-664.33K
29.78%-1.31M
-110.41%-247.68K
Cash from discontinued investing activities
Operating cash flow
23.59%-16.43M
-14.10%-21.5M
-76.21%-8.57M
31.93%-5.05M
-11.19%-18.85M
---5M
-121.36%-1.56M
-13.86%-4.87M
4.15%-7.42M
-31.21%-16.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-72.24%7.02M
76.93%25.29M
0
12.37M
-43.00%14.29M
1.12M
11.18M
-78.34%1.99M
0
98.25%25.07M
Net common stock issuance
-72.15%7.02M
76.27%25.19M
--0
--12.37M
-42.94%14.29M
--1.12M
--11.18M
-78.27%1.99M
--0
98.03%25.05M
Proceeds from stock option exercised by employees
-95.74%4K
--94K
----
----
--0
----
----
----
----
--27.5K
Cash from discontinued financing activities
Financing cash flow
-72.24%7.02M
76.93%25.29M
--0
--12.37M
-43.00%14.29M
--1.12M
--11.18M
-78.34%1.99M
--0
98.25%25.07M
Net cash flow
Beginning cash position
41.54%13.25M
-33.40%9.36M
150.78%16.72M
-33.40%9.36M
145.23%14.06M
--13.39M
-70.25%3.79M
-14.75%6.67M
145.23%14.06M
-3.96%5.73M
Current changes in cash
-348.73%-9.41M
183.10%3.78M
-198.51%-8.57M
198.63%7.32M
-156.06%-4.55M
---3.89M
1,466.72%9.62M
-158.26%-2.87M
-446.91%-7.42M
3,104.72%8.12M
Effect of exchange rate changes
-93.33%7K
174.61%105K
152.68%2.4K
44.45%44.38K
-170.18%-140.73K
---142.28K
-108.93%-24.61K
22.97%-4.56K
164.21%30.72K
488.35%200.53K
End cash Position
-70.98%3.85M
41.54%13.25M
114.98%8.15M
150.78%16.72M
-33.40%9.36M
--9.36M
8.71%13.39M
-70.25%3.79M
-14.75%6.67M
145.23%14.06M
Free cash flow
23.59%-16.43M
-14.10%-21.5M
-76.21%-8.57M
31.93%-5.05M
-11.19%-18.85M
---5M
-121.36%-1.56M
-13.86%-4.87M
4.15%-7.42M
-31.21%-16.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
(FY)Dec 31, 2023(FY)Dec 31, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.59%-16.43M-14.10%-21.5M-76.21%-8.57M31.93%-5.05M-11.19%-18.85M-5M-121.36%-1.56M-13.86%-4.87M4.15%-7.42M-31.21%-16.95M
Net income from continuing operations 43.61%-10.01M-1.86%-17.75M-30.68%-5.68M11.34%-5.18M-2.01%-17.42M---5.79M-258.89%-1.45M41.58%-4.35M-55.88%-5.84M-1.40%-17.08M
Operating gains losses -28.91%-6.85M-2,292.55%-5.32M23.60%-54.14K-131.02%-82.36K123.15%242.5K--49.21K99.90%-1.33K-104.67%-70.87K123.68%265.48K-356.84%-1.05M
Depreciation and amortization 0.00%4K-3.05%4K-10.11%942-2.71%1.01K-53.68%4.13K--1.01K4.87%1.03K-65.57%1.05K-73.33%1.03K-53.62%8.91K
Other non cash items --142K----------------------------------900K
Change In working capital -205.35%-866K141.44%822K-457.39%-2.96M105.66%109.3K-3,465.71%-1.98M--656.9K57.54%-177.73K-177.79%-531.66K35.14%-1.93M-101.80%-55.63K
-Change in prepaid assets -95.88%70K197.52%1.7M-450.96%-465.62K28.99%-442.85K-1,007.17%-1.74M---960.12K-188.11%-291.19K-11.02%132.67K44.09%-623.63K-72.96%192.05K
-Change in payables and accrued expense -6.73%-936K-263.43%-877K-272.24%-2.47M142.23%552.16K2.57%-241.31K--1.62M115.15%113.45K-224.32%-664.33K29.78%-1.31M-110.41%-247.68K
Cash from discontinued investing activities
Operating cash flow 23.59%-16.43M-14.10%-21.5M-76.21%-8.57M31.93%-5.05M-11.19%-18.85M---5M-121.36%-1.56M-13.86%-4.87M4.15%-7.42M-31.21%-16.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -72.24%7.02M76.93%25.29M012.37M-43.00%14.29M1.12M11.18M-78.34%1.99M098.25%25.07M
Net common stock issuance -72.15%7.02M76.27%25.19M--0--12.37M-42.94%14.29M--1.12M--11.18M-78.27%1.99M--098.03%25.05M
Proceeds from stock option exercised by employees -95.74%4K--94K----------0------------------27.5K
Cash from discontinued financing activities
Financing cash flow -72.24%7.02M76.93%25.29M--0--12.37M-43.00%14.29M--1.12M--11.18M-78.34%1.99M--098.25%25.07M
Net cash flow
Beginning cash position 41.54%13.25M-33.40%9.36M150.78%16.72M-33.40%9.36M145.23%14.06M--13.39M-70.25%3.79M-14.75%6.67M145.23%14.06M-3.96%5.73M
Current changes in cash -348.73%-9.41M183.10%3.78M-198.51%-8.57M198.63%7.32M-156.06%-4.55M---3.89M1,466.72%9.62M-158.26%-2.87M-446.91%-7.42M3,104.72%8.12M
Effect of exchange rate changes -93.33%7K174.61%105K152.68%2.4K44.45%44.38K-170.18%-140.73K---142.28K-108.93%-24.61K22.97%-4.56K164.21%30.72K488.35%200.53K
End cash Position -70.98%3.85M41.54%13.25M114.98%8.15M150.78%16.72M-33.40%9.36M--9.36M8.71%13.39M-70.25%3.79M-14.75%6.67M145.23%14.06M
Free cash flow 23.59%-16.43M-14.10%-21.5M-76.21%-8.57M31.93%-5.05M-11.19%-18.85M---5M-121.36%-1.56M-13.86%-4.87M4.15%-7.42M-31.21%-16.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.26%